Myo‐inositol and D‐chiro‐inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Mice exposed to continuous light undergo functional and histological changes that mimic those of human Polycystic Ovary Syndrome (PCOS). We herein induced the syndrome by exposing 30‐day‐old females to 10 weeks of permanent light. Ovarian morphology and histology, as well as reproductive parameters (time of observed pregnancy/delivery) were investigated. Ovaries of PCOS‐modeled mice showed lack of tertiary follicles and corpora lutea, altered ovarian architecture, and increased thickness of the theca layer. When mice were returned to a normal light‐dark regimen for 10 days, a slight, spontaneous improvement occurred, whereas a quick and almost complete recovery from PCOS signs and symptoms was obtained by treating animals with a daily supplementation of 420 mg/kg myo‐inositol and D‐chiro‐inositol (MyoIns/DCIns) in a 40:1 molar ratio. Namely, ovaries from mice treated by this protocol recovered normal histological features and a proper ratio of theca/granulosa cell layer thickness (TGR), suggesting that the androgenic phenotype was efficiently reversed. Indeed, we identified TGR as a useful index of PCOS, as its increase in PCOS‐modeled mice correlated linearly with reduced reproductive capability ( r = 0.75, p < 0.0001). Mice treated with a 40:1 formula regained low TGR values and faster recovery of their fertility, with a physiological delivery time after mating. On the other hand, a higher D‐chiro‐inositol treatment formula, such as MyoIns versus DCIns 5:1, was ineffective or even had a negative effect on clinical‐pathological outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Papaleo, E., Unfer, V., Baillargeon, J.-P., Fusi, F., Occhi, F., & De Santis, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.088 · Cited by 197 · cited 2×
“Furthermore, clinical trials performed on PCOS patients undergoing in vitro fertilization (IVF), have shown that MyoIns pretreatment beginning three months before the onset of ovarian stimulation produces significant improvements in hormonal responses, reduces the amount of FSH necessary for optimal follicle developme…”
BackgroundRetractedAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 1×
“The Androgen Excess and PCOS Society recommended in 2006 that PCOS can be identified by presence of hyperandrogenism and/or oligo‐ovulation and polycystic ovaries and the exclusion of other related disorders (Azziz et al., 2009).”
BackgroundAmenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121 · cited 1×
“Polycystic ovary syndrome (PCOS), first described by Stein and Leventhal (1935) as a condition of oligo‐amenorrhea and polycystic ovaries accompanied by hirsutism and obesity, is the most common endocrine disorder in reproductive age women.”
BackgroundHeritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647
Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome
Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D., & Allan, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401703 · Cited by 518
The role of genes and environment in the etiology of PCOS
Diamanti-Kandarakis, E., Kandarakis, H., & Legro, R. S. (2006) · Endocrine · doi:10.1385/endo:30:1:19 · Cited by 233
Unfer, V., Carlomagno, G., Papaleo, E., Vailati, S., Candiani, M., & Baillargeon, J.-P. (2014) · Reproductive Sciences · doi:10.1177/1933719113518985 · Cited by 105 · cited 3×
“…in the ovaries of patients with PCOS, MyoIns is continuously transformed into DCIns by hyperactivation of epimerase under insulin control (Bizzarri et al., 2016b), that leads to an unbalanced, severely decreased ratio of approximately 0.2 MyoIns:1 DCIns in the follicular fluid (Unfer et al., 2014).”
BackgroundInfluentialMelatonin and its correlation with testosterone in polycystic ovarian syndrome
Jain, M., Jain, P., Haldar, C., Singh, T., & Jain, S. (2013) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.126295 · Cited by 62
Night light alters menstrual cycles
Lin, M. C., Kripke, D. F., Perry, B. L., & Berga, S. L. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90067-f · Cited by 45
Animal models for PCOS — not the real thing
Azziz, R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.57 · Cited by 21 · cited 1×
“…shows advantages in avoiding the off‐target effects of hormone inducers, which are likely different from those naturally occurring in human PCOS, whereas producing similar features of PCOS, including irregular cycles, oligo‐anovulation, polycystic ovaries, and follicle atresia (Azziz, 2017).”
Background
Cited by
Inositols: From Established Knowledge to Novel Approaches
Dinicola, S., Unfer, V., Facchinetti, F., Soulage, C. O., Greene, N. D., Bizzarri, M., Laganà, A. S., Chan, S.-Y., Bevilacqua, A., Pkhaladze, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910575 · Cited by 154
“contributed to the first demonstration in a pre-clinical model of how the myo-Ins to D-chiro-Ins ratio influences ovarian physiology [46].”
BackgroundSelf-citationRecent advances in the understanding and management of polycystic ovary syndrome
Rocha, A. L., Oliveira, F. R., Azevedo, R. C., Silva, V. A., Peres, T. M., Candido, A. L., Gomes, K. B., & Reis, F. M. (2019) · F1000Research · doi:10.12688/f1000research.15318.1 · Cited by 142
Inositols in polycystic ovary syndrome: An overview on the advances
Facchinetti, F., Unfer, V., Dewailly, D., Kamenov, Z. A., Diamanti-Kandarakis, E., Laganà, A. S., Nestler, J. E., & Soulage, C. O. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.02.002 · Cited by 102
Kamenov, Z., & Gateva, A. (2020) · Molecules · doi:10.3390/molecules25235566 · Cited by 100
“In the experimental (mice) model of PCOS, MI/DCI treatment in a 40:1 ratio made a fast recovery from PCOS signs and symptoms, while other MI/DCI ratios were less effective or had even negative effects [111].”
MethodFacchinetti, F., Appetecchia, M., Aragona, C., Bevilacqua, A., Bezerra Espinola, M. S., Bizzarri, M., D’Anna, R., Dewailly, D., Diamanti-Kandarakis, E., Hernández Marín, I., et al. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1737675 · Cited by 63
Self-citation
Metadata
- Authors
- Bevilacqua, A., Dragotto, J., Giuliani, A., & Bizzarri, M.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2018-10-14
- Volume
- 234
- Issue
- 6
- Pages
- 9387-9398
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2897984491
- Cited by
- 84
- References
- 10
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.